Idelalisib Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-04-07 · last update 2026-04-07
Manufacturers: Gilead Sciences, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Zydelig, Tablet, 100 mg (NDC 61958-1701-1) | Gilead Sciences, Inc. | To Be Discontinued | — | Discontinuation in the manufacturing of the drug | Posted 04/07/2026 Updated 04/07/2026 Discontinued 04/07/2026 |
| Zydelig, Tablet, 150 mg (NDC 61958-1702-1) | Gilead Sciences, Inc. | To Be Discontinued | — | Discontinuation in the manufacturing of the drug | Posted 04/07/2026 Updated 04/07/2026 Discontinued 04/07/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)